Whitepapers

Who is the final decision maker about your healthcare?

20 September 2018

Who is the final decision maker about your health when…

Read More

Might international thought leaders be your best research respondents?

20 September 2018

The best thing about recruiting the very top people as…

Read More

Hemophilia and gene therapy: how it works (chapter two)

19 September 2018

Hemophilia is a rare, usually inherited, genetic disorder that inhibits…

Read More

Hemophilia and gene therapy: a short introduction (chapter one)

19 September 2018

Hemophilia is a rare, usually inherited, genetic disorder that inhibits…

Read More

Patient counselling materials and health literacy

11 September 2018

Sherry Fox at THE PLANNING SHOP has co-authored a newly…

Read More

Balancing cost:benefit in ‘well-treated’ malignancies

30 April 2018

Oncologists and pharmaceutical companies are increasingly discussing the cost:benefit ratio…

Read More

Learning from a successful ophthalmology brand launch

20 December 2017

As the ophthalmology market becomes more competitive and brands seek…

Read More

Rare disease research needs a multifaceted approach

1 November 2017

In our latest whitepaper, Caroline Mathie – Vice President, Rare…

Read More

Ambition, creativity and energy for optimal segmentation

10 March 2017

There are three guiding principles that should underlie successful market…

Read More

Healthcare marketing to Millennials: six key insights

8 November 2016

What do pharmaceutical companies need to bear in mind when…

Read More

Promise for combination approach to cancer

23 August 2016

As immuno-oncology increasingly involves more than one agent for best…

Read More

Incorporating ‘fast thinking’ into market research

27 July 2016

Accessing the ‘fast thinking’ side of the brain through digital…

Read More

Injectable therapies for dry eyes

15 July 2016

Do patients want injectable therapy for dry eyes? How can…

Read More

Commonalities in orphan diseases

18 March 2016

Identifying commonalities can help improve efficiencies in the drug development…

Read More

Segmentation for marketing new Alzheimer’s brands

18 March 2016

In order to understand the market potential of a new…

Read More

Put more disease education into oncology marketing communications

18 March 2016

As oncology treatments become increasingly more personalised, marketers need to devote…

Read More

A sea-change in rare disease drug development

23 February 2016

An overview of orphan drug development and considerations for how…

Read More

Successful brand building means solving customer problems

23 February 2016

Pharma marketers need to listen to HCPs and patients to…

Read More

Unmasking the real benefits of online and mobile communities

23 February 2016

With careful planning, online communities can provide market researchers with…

Read More

Treating co-occurring mental illness and chronic disease

23 February 2016

To date there has been little research into treatments for…

Read More